Varying intensity of postremission therapy in acute myeloid leukemia.

@article{Cassileth1992VaryingIO,
  title={Varying intensity of postremission therapy in acute myeloid leukemia.},
  author={Peter A. Cassileth and Ella Lynch and J. Dwight Hines and Martin M. Oken and Joseph J. Mazza and J. Michael Bennett and Philip B Mcglave and Menahem Edelstein and David P. Harrington and Michael J. O'Connell},
  journal={Blood},
  year={1992},
  volume={79 8},
  pages={1924-30}
}
The Eastern Cooperative Oncology Group (ECOG) conducted a randomized trial in patients less than or equal to 65 years old (median, 44 years) to determine whether increasing the intensity of postremission therapy in acute myeloid leukemia (AML) would improve the outcome. After uniform induction therapy, patients in complete remission (CR) who were less than 41 years old and who had a histocompatible sibling underwent allogeneic bone marrow transplantation (alloBMT) (54 patients). The remainder… CONTINUE READING
84 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 84 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

An ECOG trial of autologous bone marrow transplantation in first remission of acute myeloid leukemia

  • GW Santos
  • Blood
  • 1990

Similar Papers

Loading similar papers…